chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient did not receive the second vaccine dose yet and it is been more than 35 days since the first vaccine dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient did not receive the second vaccine dose yet and it is been more than 35 days since the first vaccine dose) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not receive the second vaccine dose yet and it is been more than 35 days since the first vaccine dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient did not receive the second vaccine dose yet and it is been more than 35 days since the first vaccine dose) had resolved.            No Relevant concomitant medications was reported.  Treatment information was not provided.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Chills, Feeling abnormal, Hyperhidrosis
Clinical narrative: felt so bad; flu-like symptoms; chills; sweats; runny nose; weakness/ no energy/ only wanted to rest; chest pain; tight muscles; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), RHINORRHOEA (runny nose), ASTHENIA (weakness/ no energy/ only wanted to rest), CHEST PAIN (chest pain) and MUSCLE TIGHTNESS (tight muscles) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, the patient experienced HYPERHIDROSIS (sweats), RHINORRHOEA (runny nose), ASTHENIA (weakness/ no energy/ only wanted to rest), CHEST PAIN (chest pain), MUSCLE TIGHTNESS (tight muscles) and CHILLS (chills). On 15-Jun-2021, the patient experienced FEELING ABNORMAL (felt so bad) and INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, HYPERHIDROSIS (sweats), RHINORRHOEA (runny nose), ASTHENIA (weakness/ no energy/ only wanted to rest), CHEST PAIN (chest pain), MUSCLE TIGHTNESS (tight muscles), FEELING ABNORMAL (felt so bad), INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported .
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Muscle tightness, Rhinorrhoea
Clinical narrative: felt so bad; flu-like symptoms; chills; sweats; runny nose; weakness/ no energy/ only wanted to rest; chest pain; tight muscles; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), RHINORRHOEA (runny nose), ASTHENIA (weakness/ no energy/ only wanted to rest), CHEST PAIN (chest pain) and MUSCLE TIGHTNESS (tight muscles) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, the patient experienced HYPERHIDROSIS (sweats), RHINORRHOEA (runny nose), ASTHENIA (weakness/ no energy/ only wanted to rest), CHEST PAIN (chest pain), MUSCLE TIGHTNESS (tight muscles) and CHILLS (chills). On 15-Jun-2021, the patient experienced FEELING ABNORMAL (felt so bad) and INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, HYPERHIDROSIS (sweats), RHINORRHOEA (runny nose), ASTHENIA (weakness/ no energy/ only wanted to rest), CHEST PAIN (chest pain), MUSCLE TIGHTNESS (tight muscles), FEELING ABNORMAL (felt so bad), INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported .
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Influenza like illness, Myalgia
Clinical narrative: cold flu symptoms; severe reaction; cold flu symptoms; persistent sinus headache,it feels like a pressure behind the eyes and forehead, specially when patient coughs or stands up really fast; chills; muscle aches/body aches; got tired very easily; very bad headache/sharp pain in the head; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold flu symptoms), VACCINATION COMPLICATION (severe reaction), INFLUENZA LIKE ILLNESS (cold flu symptoms), SINUS HEADACHE (persistent sinus headache,it feels like a pressure behind the eyes and forehead, specially when patient coughs or stands up really fast) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CANNABIS SATIVA (CANNABIS) for an unknown indication.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold flu symptoms), VACCINATION COMPLICATION (severe reaction), INFLUENZA LIKE ILLNESS (cold flu symptoms), SINUS HEADACHE (persistent sinus headache,it feels like a pressure behind the eyes and forehead, specially when patient coughs or stands up really fast), CHILLS (chills), MYALGIA (muscle aches/body aches), FATIGUE (got tired very easily) and HEADACHE (very bad headache/sharp pain in the head). At the time of the report, NASOPHARYNGITIS (cold flu symptoms), VACCINATION COMPLICATION (severe reaction), INFLUENZA LIKE ILLNESS (cold flu symptoms), SINUS HEADACHE (persistent sinus headache,it feels like a pressure behind the eyes and forehead, specially when patient coughs or stands up really fast), CHILLS (chills), MYALGIA (muscle aches/body aches), FATIGUE (got tired very easily) and HEADACHE (very bad headache/sharp pain in the head) outcome was unknown.            Treatment information not provided.   This case was linked to MOD-2021-223956 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Sinus headache, Vaccination complication
Clinical narrative: cold flu symptoms; severe reaction; cold flu symptoms; persistent sinus headache,it feels like a pressure behind the eyes and forehead, specially when patient coughs or stands up really fast; chills; muscle aches/body aches; got tired very easily; very bad headache/sharp pain in the head; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold flu symptoms), VACCINATION COMPLICATION (severe reaction), INFLUENZA LIKE ILLNESS (cold flu symptoms), SINUS HEADACHE (persistent sinus headache,it feels like a pressure behind the eyes and forehead, specially when patient coughs or stands up really fast) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CANNABIS SATIVA (CANNABIS) for an unknown indication.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold flu symptoms), VACCINATION COMPLICATION (severe reaction), INFLUENZA LIKE ILLNESS (cold flu symptoms), SINUS HEADACHE (persistent sinus headache,it feels like a pressure behind the eyes and forehead, specially when patient coughs or stands up really fast), CHILLS (chills), MYALGIA (muscle aches/body aches), FATIGUE (got tired very easily) and HEADACHE (very bad headache/sharp pain in the head). At the time of the report, NASOPHARYNGITIS (cold flu symptoms), VACCINATION COMPLICATION (severe reaction), INFLUENZA LIKE ILLNESS (cold flu symptoms), SINUS HEADACHE (persistent sinus headache,it feels like a pressure behind the eyes and forehead, specially when patient coughs or stands up really fast), CHILLS (chills), MYALGIA (muscle aches/body aches), FATIGUE (got tired very easily) and HEADACHE (very bad headache/sharp pain in the head) outcome was unknown.            Treatment information not provided.   This case was linked to MOD-2021-223956 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: More than 42 days after First shot and she has not received the Second dose/More then 50 days after 1st shot; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 42 days after First shot and she has not received the Second dose/More then 50 days after 1st shot) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 42 days after First shot and she has not received the Second dose/More then 50 days after 1st shot). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 42 days after First shot and she has not received the Second dose/More then 50 days after 1st shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment medications were not provided by the reporter. The patient reported it have been more than 50 days after first dose.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up information received on 16-JUN-2021: Event details added.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumococcal immunisation
Clinical narrative: This spontaneous case reported by a healthcare professional, describes the occurrence of pneumococcal immunisation (took pneumonia shot 2 days after the Moderna vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 013M20A) for COVID-19 immunization. No medical history reported. On Feb 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 8, 2021, patient experienced pneumococcal immunisation (took pneumonia shot 2 days after the Moderna vaccine). At the time of the report, pneumococcal immunisation (took pneumonia shot 2 days after the Moderna vaccine): unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments, concomitant product use or treatment information.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain upper, Gastrointestinal sounds abnormal, Insomnia
Clinical narrative: Couldn't sleep; Stomach popping; Stomach cramping and painful; Sharp pain for 8 hours in the stomach; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Couldn't sleep), GASTROINTESTINAL SOUNDS ABNORMAL (Stomach popping), ABDOMINAL PAIN UPPER (Stomach cramping and painful) and ABDOMINAL PAIN UPPER (Sharp pain for 8 hours in the stomach) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Couldn't sleep), GASTROINTESTINAL SOUNDS ABNORMAL (Stomach popping), ABDOMINAL PAIN UPPER (Stomach cramping and painful) and ABDOMINAL PAIN UPPER (Sharp pain for 8 hours in the stomach). At the time of the report, INSOMNIA (Couldn't sleep), GASTROINTESTINAL SOUNDS ABNORMAL (Stomach popping) and ABDOMINAL PAIN UPPER (Stomach cramping and painful) outcome was unknown and ABDOMINAL PAIN UPPER (Sharp pain for 8 hours in the stomach) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given a dose from vial that had been punctured more than 12 hours prior) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given a dose from vial that had been punctured more than 12 hours prior). On 12-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Patient was given a dose from vial that had been punctured more than 12 hours prior) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: it was red; (It was) very itchy & It has gotten worse; (It was) hot; Hard knot at the injection site & it was raised & It has gotten worse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH ((It was) hot), VACCINATION SITE INDURATION (Hard knot at the injection site & it was raised & It has gotten worse), VACCINATION SITE PRURITUS ((It was) very itchy & It has gotten worse) and VACCINATION SITE ERYTHEMA (it was red) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C71A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced VACCINATION SITE INDURATION (Hard knot at the injection site & it was raised & It has gotten worse). On 10-Jun-2021, the patient experienced VACCINATION SITE WARMTH ((It was) hot) and VACCINATION SITE PRURITUS ((It was) very itchy & It has gotten worse). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (it was red). At the time of the report, VACCINATION SITE WARMTH ((It was) hot), VACCINATION SITE INDURATION (Hard knot at the injection site & it was raised & It has gotten worse), VACCINATION SITE PRURITUS ((It was) very itchy & It has gotten worse) and VACCINATION SITE ERYTHEMA (it was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported. Treatment medication was not provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), MYALGIA (Body Aches) and NAUSEA (Nausea) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Allergy, LAMOTRIGINE for Antidepressant therapy, CLONAZEPAM for Anxiety, LISINOPRIL for Blood pressure abnormal, HYDROCHLOROTHIAZIDE for Blood pressure high, TIZANIDINE for Muscle relaxant. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), MYALGIA (Body Aches) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. On 12-Mar-2021, PAIN IN EXTREMITY (Arm Pain), MYALGIA (Body Aches) and NAUSEA (Nausea) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Greater than 35 days from the first Moderna Covid-19 vaccine prior to receiving the second Moderna Covid-19 vaccine.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Greater than 35 days from the first Moderna Covid-19 vaccine prior to receiving the second Moderna Covid-19 vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Greater than 35 days from the first Moderna Covid-19 vaccine prior to receiving the second Moderna Covid-19 vaccine.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Greater than 35 days from the first Moderna Covid-19 vaccine prior to receiving the second Moderna Covid-19 vaccine.) had resolved.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 14.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: vaccine was accidentally given to a 14 year old; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine was accidentally given to a 14 year old) in a 14-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine was accidentally given to a 14 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (vaccine was accidentally given to a 14 year old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Fatigue, Influenza like illness, Myalgia, Nausea
Clinical narrative: Flu-like symptoms; Bruise at the injection site; Fever; Nausea; Muscle aches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea) and MYALGIA (Muscle aches) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Muscle aches) and FATIGUE (Fatigue). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Muscle aches) and FATIGUE (Fatigue) had resolved.            No, Concomitant medication was provided. No, Treatment was provided. Patient had the first dose of the Moderna COVID-19 vaccine on 18May2021 (lot # 033C21A).  Immediately after the shot, the patient felt flu-like symptoms, nausea, muscle aches, and fatigue. These got better after about 2 days.   This case was linked to MOD-2021-224140 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received on 30 Jul 2021, Updated the outcome for the events.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Flu-like symptoms; Bruise at the injection site; Fever; Nausea; Muscle aches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea) and MYALGIA (Muscle aches) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Muscle aches) and FATIGUE (Fatigue). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), CONTUSION (Bruise at the injection site), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Muscle aches) and FATIGUE (Fatigue) had resolved.            No, Concomitant medication was provided. No, Treatment was provided. Patient had the first dose of the Moderna COVID-19 vaccine on 18May2021 (lot # 033C21A).  Immediately after the shot, the patient felt flu-like symptoms, nausea, muscle aches, and fatigue. These got better after about 2 days.   This case was linked to MOD-2021-224140 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received on 30 Jul 2021, Updated the outcome for the events.
Sex: U
Vaccine: COVID19
Symptoms: Exposure via breast milk, Headache, Pain in extremity
Clinical narrative: Sore arm; Breastfeeding; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), EXPOSURE VIA BREAST MILK (Breastfeeding) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), EXPOSURE VIA BREAST MILK (Breastfeeding) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown and EXPOSURE VIA BREAST MILK (Breastfeeding) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Weight decreased
Clinical narrative: Loss of appetite; Weight loss; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite) and WEIGHT DECREASED (Weight loss) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008E21A and 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Loss of appetite) and WEIGHT DECREASED (Weight loss). At the time of the report, DECREASED APPETITE (Loss of appetite) and WEIGHT DECREASED (Weight loss) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.     Relevant concomitant medications were not reported.  Treatment medication information was not reported.  The patient had a rough month in may and was ok now.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant follow up : outcome of both the events Loss of appetite and weight loss were updated
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose of the vaccine after 3 weeks from the first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of the vaccine after 3 weeks from the first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On 16-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of the vaccine after 3 weeks from the first shot). On 16-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose of the vaccine after 3 weeks from the first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: It has been 50 days after my first Maderna COVID 19 Vaccine Should I get my second shot?; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It has been 50 days after my first Maderna COVID 19 Vaccine Should I get my second shot?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It has been 50 days after my first Maderna COVID 19 Vaccine Should I get my second shot?). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It has been 50 days after my first Maderna COVID 19 Vaccine Should I get my second shot?) had resolved.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site bruising
Clinical narrative: Bruise at the injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruise at the injection site) and PYREXIA (Fever) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, the patient experienced PYREXIA (Fever). On 16-Jun-2021, the patient experienced VACCINATION SITE BRUISING (Bruise at the injection site). At the time of the report, VACCINATION SITE BRUISING (Bruise at the injection site) and PYREXIA (Fever) had resolved.            No concomitant medications were provided.  Patient was noticed a bruise at injection site and stated it was like  a spider web pattern, webbing out into the blood vessels.  The patient reported that he had recovered from his symptoms after a couple of days.  No treatment was reported.   This case was linked to MOD-2021-224104 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow up information received and contains significant information .outcome of the events updated from unknown to recovered/Resolved.
Sex: U
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Is it normal to feel sleepy one hour after the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Is it normal to feel sleepy one hour after the vaccination?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Is it normal to feel sleepy one hour after the vaccination?). At the time of the report, SOMNOLENCE (Is it normal to feel sleepy one hour after the vaccination?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications was provided.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: 101 fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (101 fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (101 fever). At the time of the report, PYREXIA (101 fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment drug information provided. No concomitant drug information provided.
Sex: U
Vaccine: COVID19
Symptoms: Hypersomnia
Clinical narrative: Sleep a great deal extra for four weeks; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Sleep a great deal extra for four weeks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSOMNIA (Sleep a great deal extra for four weeks). At the time of the report, HYPERSOMNIA (Sleep a great deal extra for four weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Nervousness
Clinical narrative: Nervousness; myalgia; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (Nervousness) and MYALGIA (myalgia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, the patient experienced NERVOUSNESS (Nervousness) and MYALGIA (myalgia). At the time of the report, NERVOUSNESS (Nervousness) and MYALGIA (myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided by the reporter and no concomitant medication reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Extremely tired; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (Extremely tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Extremely tired). At the time of the report, FATIGUE (Extremely tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Movement disorder, Pain in extremity
Clinical narrative: He can barely lift anything with left arm; Patient reports that he had a sore left arm after receiving 1st dose on 3rd day; He could barely lift his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Patient reports that he had a sore left arm after receiving 1st dose on 3rd day), MOVEMENT DISORDER (He could barely lift his arm) and MOBILITY DECREASED (He can barely lift anything with left arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 044A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (Patient reports that he had a sore left arm after receiving 1st dose on 3rd day) and MOVEMENT DISORDER (He could barely lift his arm). On an unknown date, the patient experienced MOBILITY DECREASED (He can barely lift anything with left arm). At the time of the report, PAIN IN EXTREMITY (Patient reports that he had a sore left arm after receiving 1st dose on 3rd day), MOVEMENT DISORDER (He could barely lift his arm) and MOBILITY DECREASED (He can barely lift anything with left arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products included Blood pressure medication, Anti-depressants and ANTIBIOTICS for an unknown indication.  Treatment reported such as  Ice, heating pad, muscle rub.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable   This case was linked to MOD-2021-224267 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Skin rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (skin rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (skin rash). At the time of the report, RASH (skin rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Vomiting
Clinical narrative: nausea; Throwing up; headache; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), NAUSEA (nausea), VOMITING (Throwing up) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033b21A and 025621a) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Jun-2021, the patient experienced FATIGUE (tiredness). On 16-Jun-2021, the patient experienced NAUSEA (nausea), VOMITING (Throwing up) and HEADACHE (headache). At the time of the report, FATIGUE (tiredness), NAUSEA (nausea), VOMITING (Throwing up) and HEADACHE (headache) outcome was unknown.            No concomitant information was provided. No treatment medication was provided. Patient asked if it was alright to take an antacid.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow-up information received on 15 Jul 2021 contains non significant information.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 4 expired doses administered to four patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 expired doses administered to four patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 expired doses administered to four patients). On 15-Jun-2021, EXPIRED PRODUCT ADMINISTERED (4 expired doses administered to four patients) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Got first dose of the vaccine 2 months ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Got first dose of the vaccine 2 months ago) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Got first dose of the vaccine 2 months ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Got first dose of the vaccine 2 months ago) had resolved.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal, Nasopharyngitis, Taste disorder
Clinical narrative: Feel like getting a cold; Have a bad taste in throat; Felt bad the following day; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Feel like getting a cold), TASTE DISORDER (Have a bad taste in throat) and FEELING ABNORMAL (Felt bad the following day) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Feel like getting a cold), TASTE DISORDER (Have a bad taste in throat) and FEELING ABNORMAL (Felt bad the following day). At the time of the report, NASOPHARYNGITIS (Feel like getting a cold), TASTE DISORDER (Have a bad taste in throat) and FEELING ABNORMAL (Felt bad the following day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was reported
Sex: M
Vaccine: COVID19
Symptoms: Movement disorder, Pain in extremity
Clinical narrative: Pain in arms; Movement difficulty; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arms) and MOVEMENT DISORDER (Movement difficulty) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arms) and MOVEMENT DISORDER (Movement difficulty). At the time of the report, PAIN IN EXTREMITY (Pain in arms) and MOVEMENT DISORDER (Movement difficulty) had not resolved.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Peripheral swelling
Clinical narrative: Alot of pain; Swollen arm; Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Alot of pain), PERIPHERAL SWELLING (Swollen arm) and LYMPHADENOPATHY (Swollen lymph nodes) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 027C21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and ATORVASTATIN for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PAIN (Alot of pain), PERIPHERAL SWELLING (Swollen arm) and LYMPHADENOPATHY (Swollen lymph nodes). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Apr-2021, PERIPHERAL SWELLING (Swollen arm) and LYMPHADENOPATHY (Swollen lymph nodes) had resolved. At the time of the report, PAIN (Alot of pain) had not resolved.            Pain is still ongoing and getting worse.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pyrexia
Clinical narrative: Felt very sick with fever and chills; Felt very sick with fever and chills; felt very sick with fever and chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt very sick with fever and chills), PYREXIA (Felt very sick with fever and chills) and CHILLS (felt very sick with fever and chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced MALAISE (Felt very sick with fever and chills), PYREXIA (Felt very sick with fever and chills) and CHILLS (felt very sick with fever and chills). On 19-Jan-2021, MALAISE (Felt very sick with fever and chills), PYREXIA (Felt very sick with fever and chills) and CHILLS (felt very sick with fever and chills) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   ?No treatment information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Hand and feet aching; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hand and feet aching) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Hand and feet aching). At the time of the report, PAIN IN EXTREMITY (Hand and feet aching) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   ? No treatment information was provided. ? The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. ? Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-224554 (Patient Link).